Cargando…

Long‐term quality of life after definitive treatment for prostate cancer: patient‐reported outcomes in the second posttreatment decade

Definitive treatment for prostate cancer includes radical prostatectomy (RP), external beam radiation therapy (EBRT), and brachytherapy (BT). The different side effect profiles of these options are crucial factors for patients and clinicians when deciding between treatments. This study reports long‐...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Joanne W., Drumm, Michael R., Efstathiou, Jason A., Paly, Jonathan J., Niemierko, Andrzej, Ancukiewicz, Marek, Talcott, James A., Clark, Jack A., Zietman, Anthony L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504320/ https://www.ncbi.nlm.nih.gov/pubmed/28560840 http://dx.doi.org/10.1002/cam4.1103

Ejemplares similares

Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis
por: Mitani, Seiichiro, et al.
Publicado: (2019)

Prostate cancer survivors: Risk and mortality in second primary cancers
por: Chattopadhyay, Subhayan, et al.
Publicado: (2018)

Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes
por: Swaika, Abhisek, et al.
Publicado: (2017)

Time patterns of recurrence and second primary tumors in a large cohort of patients treated for oral cavity cancer
por: Brands, Maria T., et al.
Publicado: (2019)

Is there a role for IGF‐1 in the development of second primary cancers?
por: Shanmugalingam, Thurkaa, et al.
Publicado: (2016)

Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer
por: Brooks, Jennifer D., et al.
Publicado: (2016)

Second primary cancer after female breast cancer: Familial risks and cause of death
por: Zheng, Guoqiao, et al.
Publicado: (2018)

Mortality of lung cancer as a second primary malignancy: A population‐based cohort study
por: Deng, Lei, et al.
Publicado: (2019)

Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population‐based study
por: Bao, Shengnan, et al.
Publicado: (2021)

Risk of thyroid as a first or second primary cancer. A population‐based study in Italy, 1998–2012
por: Crocetti, Emanuele, et al.
Publicado: (2021)

Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor
por: Zheng, Guoqiao, et al.
Publicado: (2020)

Increased risk of second primary malignancies among endometrial cancer survivors receiving surgery alone: A population‐based analysis
por: Lai, Yen‐Ling, et al.
Publicado: (2021)

Incidence and relative risk of metachronous second primary cancers for 16 cancer sites, Osaka, Japan, 2000–2015: Population‐based analysis
por: Odani, Satomi, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on Prostate Cancer Radiotherapy Practice Patterns: A Northeast Regional Longitudinal Survey Study
por: Kamran, S.C., et al.
Publicado: (2021)

A mortality study of beryllium workers
por: Boffetta, Paolo, et al.
Publicado: (2016)

Ten‐year immune persistence and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in females vaccinated at 15–55 years of age
por: Schwarz, Tino F., et al.
Publicado: (2017)

Long-term impact of a faculty mentoring program in academic medicine
por: Efstathiou, Jason A., et al.
Publicado: (2018)

Diffusion of digital breast tomosynthesis among women in primary care: associations with insurance type
por: Clark, Cheryl R., et al.
Publicado: (2017)

Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score
por: Herget, Kimberly A., et al.
Publicado: (2015)

BMI trajectories and risk of overall and grade‐specific prostate cancer: An observational cohort study among men seen for prostatic conditions
por: Wang, Kai, et al.
Publicado: (2018)

Prostate cancer surveillance by occupation and industry: the Canadian Census Health and Environment Cohort (CanCHEC)
por: Sritharan, Jeavana, et al.
Publicado: (2018)

Tobacco smoking, polymorphisms in carcinogen metabolism enzyme genes, and risk of localized and advanced prostate cancer: results from the California Collaborative Prostate Cancer Study
por: Shahabi, Ahva, et al.
Publicado: (2014)

Association of statin use with risk of Gleason score‐specific prostate cancer: A hospital‐based cohort study
por: Wang, Kai, et al.
Publicado: (2019)

Assessment of expression levels of leptin and leptin receptor as potential biomarkers for risk of prostate cancer development and aggressiveness
por: Kamel, Hala Fawzy Mohamed, et al.
Publicado: (2020)

Determinants of quality prostate cancer survivorship care across the primary and specialty care interface: Lessons from the Veterans Health Administration
por: Radhakrishnan, Archana, et al.
Publicado: (2019)

Socioeconomic status and survival outcomes in elderly cancer patients: A national health insurance service‐elderly sample cohort study
por: Jang, Bum‐Sup, et al.
Publicado: (2019)

Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios
por: Getaneh, Abraham M., et al.
Publicado: (2020)

Opioid use by cancer status and time since diagnosis among older adults enrolled in the Prostate, Lung, Colorectal, and Ovarian screening trial in the United States
por: Durham, Danielle D., et al.
Publicado: (2021)

Association between PSA values and surveillance quality after prostate cancer surgery
por: Chapman, Christina Hunter, et al.
Publicado: (2019)

A review of hair product use on breast cancer risk in African American women
por: Stiel, Laura, et al.
Publicado: (2016)

Fatherhood status in relation to prostate cancer risks in two large U.S.‐based prospective cohort studies
por: Geczik, Ashley M., et al.
Publicado: (2020)

Race, tumor location, and disease progression among low‐risk prostate cancer patients
por: Mygatt, Justin G., et al.
Publicado: (2020)

Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER‐Medicare investigation
por: Beebe‐Dimmer, Jennifer L., et al.
Publicado: (2019)

Risk factors of cervical cancer after a negative cytological diagnosis in Polish cervical cancer screening programme
por: Macios, Anna, et al.
Publicado: (2021)

Years of life lived with disease and years of potential life lost in children who die of cancer in the United States, 2009
por: de Blank, Peter M, et al.
Publicado: (2015)

Exposure to welding fumes increases lung cancer risk among light smokers but not among heavy smokers: evidence from two case–control studies in Montreal
por: Vallières, Eric, et al.
Publicado: (2012)

Smoking status before and after colorectal cancer diagnosis and mortality in Korean men: A population‐based cohort study
por: Jang, Doeun, et al.
Publicado: (2020)

Nonsteroidal anti‐inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP study
por: Doat, Solene, et al.
Publicado: (2017)

Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population‐based cohort study
por: Kuo, Yu‐Jui, et al.
Publicado: (2019)

Long‐term health‐related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer
por: Talala, Kirsi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e6kjo8afb7edb30rc0ov1d8toc